Creative Biolabs-Immuno-oncology

Anti-CASP8 (clone IX-0Z9Q4I) SynExpress pB-Cy5-I4-H Modified CD8+ T cells (CAT#: ITS-1224-CR579)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CASP8 (clone IX-0Z9Q4I). We employs the AAV (pBAD-Cy5-IL-4-HindIII) vector components and the SynExpress system of the Histone modification sites RNA Editing/Negative feedback for a robust and sustained response against cancers.
Host
Rabbit
Target
CASP8
Clone
IX-0Z9Q4I
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy5
Promoter
pBAD
Effector Gene
IL-4
Insertion Sites
HindIII
Gene Modification
RNA Editing
Modification Domain
Histone modification sites
Carrier Type
AAV
Transformation Accuracy
0.95
Cell Culture
Adherent Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.